Vamshi Rao
Neurology with Special Qualifications in Child Neurology · Chicago, ILNPI 1770731374
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 23.1%. Reporting peaked in 2020 at $41,981 and has fallen 63.5% since, to $15,341 in 2024. Among neurology with special qualifications in child neurology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 104 payments — averaging $1192.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$29K
- Biogen$26K
- Genentech USA, Inc.$20K
- PTC Therapeutics, Inc.$19K
- Sarepta Therapeutics, Inc.$18K
- Catalyst Pharmaceuticals, Inc.$7K
- plus $5K from 5 others
Across 70 payments — averaging $7940.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- NS Pharma, Inc.$286K
- AstraZeneca$207K
- Sarepta Therapeutics, Inc.$51K
- UCB Biosciences Inc.$12K
What the payments were for
- Consulting fees$55,85545%
- Speaking & faculty fees$59,29948%
- Travel & lodging$6,7035%
- Food & beverage$2,1682%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 26 | $28,596 |
| Biogen | 17 | $25,575 |
| Genentech USA, Inc. | 15 | $19,597 |
| PTC Therapeutics, Inc. | 16 | $19,430 |
| Sarepta Therapeutics, Inc. | 16 | $18,474 |
| Catalyst Pharmaceuticals, Inc. | 6 | $7,407 |
| ITF Therapeutics LLC | 1 | $1,800 |
| Mallinckrodt Enterprises LLC | 2 | $1,700 |
| NS Pharma, Inc. | 3 | $1,295 |
| Genentech, Inc. | 1 | $126 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$124,025 in reported general payments places this provider in the 90th percentile of 57 neurology with special qualifications in child neurology providers in Illinois.
See all neurology with special qualifications in child neurology providers in Illinois →
Other neurology with special qualifications in child neurology in Chicago
- Douglas NordliChicago$621K
- Nancy KuntzChicago$503K
- John MillichapChicago$84K
- Sookyong KohChicago$60K
- Elizabeth Berry-KravisChicago$38K
- Colleen BuhrfiendChicago$15K
- Bridget McGowanChicago$11K
- Peter HeydemannChicago$11K
- Divya DesaiChicago$3K
- Joseph CollinsChicago$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.